InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Elkins David V, Chief Financial Officer. Director active across 1 companies, notably Bristol Myers Squibb Co. Cumulatively, 10 disclosures have been logged. Total volume traded: €4.6m. The latest transaction was disclosed on 10 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
08,025 shares0
Common Stock, $0.10 par value
SEC:0000014272-22-000075:0·
024,577 shares0
Common Stock, $0.10 par value
SEC:0000014272-22-000056:0·
047,401 shares0
Common Stock, $0.10 par value
SEC:0000014272-22-000017·
047,401 shares0
Common Stock, $0.10 par value
SEC:0000014272-22-000017:0·
08,792 shares0
Common Stock, $0.10 par value
SEC:0000014272-21-000230·
08,792 shares0
Common Stock, $0.10 par value
SEC:0000014272-21-000230:0·
€2m40,000 shares@ €56.9858100.0% of flow
Common Stock, $0.10 par value
SEC:0000014272-21-000202·
€2m40,000 shares@ €56.985850.0% of flow
Common Stock, $0.10 par value
SEC:0000014272-21-000202:0·
046,403 shares0
Common Stock, $0.10 par value
SEC:0000014272-21-000195·
046,403 shares0
Common Stock, $0.10 par value
SEC:0000014272-21-000195:0·
10 of 10 declarations
About Elkins David V
David V. Elkins is Executive Vice President and Chief Financial Officer at Bristol Myers Squibb Co. He is responsible for the company's financial management, including strategic planning and performance analysis. David plays a key role in guiding the company's financial direction and strategic decision-making.
